Test of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called SCTB14 for people with advanced solid tumors. The goal is to see if it is safe and whether it helps shrink or slow the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to be reasonably active — able to care for yourself and do most daily activities.
- Your cancer must have spread or be advanced, and you must have a life expectancy of more than 3 months.
- Your liver, kidneys, and blood counts should be adequate.
- No active brain or spinal cord metastases, and no history of other cancers in the past 5 years (except certain cured skin or cervical cancers).
- You must not have had cancer treatment (like chemo or immunotherapy) within the last 4 weeks, and you need to be able to avoid pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SCTB41 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it shrinks tumors.
This trial tests a new drug, SCTB39G, for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it can shrink tumors and improve survival, and to find the best dose. Participation involves regular treatment and check-ups.
This trial tests two new study drugs (SCTB41 and SCTB39-1) given together, sometimes with standard treatment, to see if they are safe and effective against advanced solid tumors. If you join, you will receive these drugs and be monitored for how well they fight the cancer.
This trial tests a new drug called SCTB39-1 for people with advanced solid tumors that have not responded to other treatments. The study has two parts: first finding the right dose, then testing how well it works.
This trial tests a new combination of two investigational drugs (SCTB41 and SCTB39G), sometimes given with standard treatment, for advanced solid tumors. The goal is to see if this approach can shrink tumors and control the cancer, and it may be an option for people who have exhausted standard treatments.
This trial tests a new drug, SCTB14, as a first treatment for advanced non-small cell lung cancer that has a high level of PD-L1. It aims to see if the drug is safe and effective for people who haven't had other treatments for their cancer.
Hear when a new Advanced Malignant Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.